Among 926 GC cases, 101 (11%) were GPC3‐GC and both diffuse and focal GPC3‐GC showed nodal metastasis more frequently (67% and 55%, respectively) than GPC3‐negative GC (34%), suggesting that GPC3 acts as an oncogene in gastric cancer [7]. The gene discussed is GPC3; the disease is gastric cancer.